When the FDA issued its final guidance for recommendations on breast implants at the end of [September], it left some plastic surgeons scratching their heads. 

While the original guidance was drafted back in 2019, this latest version “provides recommendations for manufacturers to incorporate a boxed warning and a patient-decision checklist into the labeling for breast implants to better ensure certain information is received and understood by patients.” In addition, the new guidance recommends additional labeling information, including updates to the silicone gel-filled breast implant rupture screening recommendations.

Read the full article at www.newbeauty.com